O	O	O	0	12	Constitutive	Constitutive	B-NP	JJ	O	6	NMOD	O
O	O	O	13	20	nuclear	nuclear	I-NP	JJ	B-protein	6	NMOD	B-protein
T6	B-Entity	B-Entity	21	23	NF	NF	I-NP	NN	I-protein	6	NMOD	I-protein
T6	I-Entity	I-Entity	23	24	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T6	I-Entity	I-Entity	24	29	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T6	I-Entity	I-Entity	30	31	B	B	I-NP	NN	I-protein	0	ROOT	I-protein
O	O	O	32	34	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	35	40	cells	cell	B-NP	NNS	O	7	PMOD	O
O	O	O	41	43	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	44	47	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	48	56	monocyte	monocyte	I-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	O	57	64	lineage	lineage	I-NP	NN	I-cell_type	9	PMOD	I-cell_type
O	O	O	64	65	.	.	O	.	O	6	P	O

O	O	O	67	69	In	In	B-PP	IN	O	11	VMOD	O
O	O	O	70	79	monocytes	monocyte	B-NP	NNS	B-cell_type	1	PMOD	B-cell_type
O	O	O	79	80	,	,	O	,	O	11	P	O
O	O	O	81	84	the	the	B-NP	DT	O	10	NMOD	O
T7	B-Entity	B-Entity	85	92	nuclear	nuclear	I-NP	JJ	B-protein	10	NMOD	B-protein
T7	I-Entity	I-Entity	93	99	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	100	102	NF	NF	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	102	103	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	103	108	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T7	I-Entity	I-Entity	109	110	B	B	I-NP	NN	I-protein	11	SUB	I-protein
O	O	O	111	114	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	115	119	been	be	I-VP	VBN	O	11	VC	O
O	O	O	120	127	invoked	invoke	I-VP	VBN	O	12	VC	O
O	O	O	128	130	as	as	B-PP	IN	O	13	VMOD	O
O	O	O	131	133	an	an	B-NP	DT	O	16	NMOD	O
O	O	O	134	143	important	important	I-NP	JJ	O	14	PMOD	O
O	O	O	144	157	transcription	transcription	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	158	164	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	165	167	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	168	171	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	172	182	expression	expression	I-NP	NN	O	19	PMOD	O
O	O	O	183	185	of	of	B-PP	IN	O	21	NMOD	O
T8	B-Entity	B-Entity	186	194	cytokine	cytokine	B-NP	NN	B-DNA	24	NMOD	B-DNA
T8	I-Entity	I-Entity	195	200	genes	gene	I-NP	NNS	I-DNA	22	PMOD	I-DNA
O	O	O	200	201	,	,	O	,	O	24	P	O
O	O	O	202	204	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	205	209	cell	cell	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	209	210	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
O	O	O	210	217	surface	surface	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	218	227	receptors	receptor	I-NP	NNS	I-protein	26	PMOD	I-protein
O	O	O	228	231	and	and	B-PP	CC	O	26	PMOD	O
O	O	O	232	234	in	in	B-PP	IN	O	26	PMOD	O
O	O	O	235	238	the	the	B-NP	DT	O	34	NMOD	O
O	O	O	239	249	expression	expression	I-NP	NN	O	32	PMOD	O
O	O	O	250	252	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	253	258	human	human	B-NP	JJ	O	38	NMOD	O
O	O	O	259	275	immunodeficiency	immunodeficiency	I-NP	NN	O	38	NMOD	O
O	O	O	276	281	virus	virus	I-NP	NN	O	35	PMOD	O
O	O	O	281	282	.	.	O	.	O	11	P	O

O	O	O	283	285	In	In	B-PP	IN	O	13	VMOD	O
O	O	O	286	290	such	such	B-NP	JJ	O	3	NMOD	O
O	O	O	291	296	cells	cell	I-NP	NNS	O	1	PMOD	O
O	O	O	296	297	,	,	O	,	O	13	P	O
O	O	O	298	301	DNA	DNA	B-NP	NN	O	7	NMOD	O
O	O	O	302	309	binding	binding	I-NP	NN	O	7	NMOD	O
O	O	O	310	318	activity	activity	I-NP	NN	O	13	SUB	O
O	O	O	319	321	of	of	B-PP	IN	O	7	NMOD	O
T9	B-Entity	B-Entity	322	324	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T9	I-Entity	I-Entity	324	325	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T9	I-Entity	I-Entity	325	330	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T9	I-Entity	I-Entity	331	332	B	B	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	333	336	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	337	339	be	be	I-VP	VB	O	13	VC	O
O	O	O	340	348	detected	detect	I-VP	VBN	O	14	VC	O
O	O	O	349	356	without	without	B-PP	IN	O	15	VMOD	O
O	O	O	357	368	intentional	intentional	B-NP	JJ	O	18	NMOD	O
O	O	O	369	380	stimulation	stimulation	I-NP	NN	O	16	PMOD	O
O	O	O	380	381	.	.	O	.	O	13	P	O

O	O	O	382	384	In	In	B-PP	IN	O	33	VMOD	O
O	O	O	385	388	our	our	B-NP	PRP$	O	3	NMOD	O
O	O	O	389	396	studies	study	I-NP	NNS	O	1	PMOD	O
O	O	O	396	397	,	,	O	,	O	33	P	O
O	O	O	398	403	cells	cell	B-NP	NNS	O	33	SUB	O
O	O	O	404	406	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	407	410	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	411	416	human	human	I-NP	JJ	B-cell_line	10	NMOD	B-cell_line
O	O	O	417	426	monocytic	monocytic	I-NP	JJ	I-cell_line	10	NMOD	I-cell_line
O	O	O	427	431	line	line	I-NP	NN	I-cell_line	12	NMOD	I-cell_line
O	O	O	432	436	Mono	Mono	I-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	O	437	440	Mac	Mac	I-NP	NN	I-cell_line	6	PMOD	I-cell_line
O	O	O	441	442	6	6	I-NP	CD	I-cell_line	12	NMOD	I-cell_line
O	O	O	442	443	,	,	O	,	O	5	P	O
O	O	O	444	452	cultured	culture	B-VP	VBN	O	5	NMOD	O
O	O	O	453	455	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	456	462	medium	medium	B-NP	NN	O	16	PMOD	O
O	O	O	463	473	containing	contain	B-VP	VBG	O	17	NMOD	O
O	O	O	474	479	fetal	fetal	B-NP	JJ	O	25	NMOD	O
O	O	O	479	480	-	-	I-NP	HYPH	O	25	P	O
O	O	O	480	484	calf	calf	I-NP	NN	O	22	NMOD	O
O	O	O	485	490	serum	serum	I-NP	NN	O	25	NMOD	O
O	O	O	491	494	and	and	O	CC	O	25	NMOD	O
O	O	O	495	498	low	low	B-NP	JJ	O	25	NMOD	O
O	O	O	499	505	levels	level	I-NP	NNS	O	18	OBJ	O
O	O	O	506	508	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	509	527	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	26	PMOD	O
O	O	O	528	529	(	(	O	(	O	30	DEP	O
O	O	O	529	532	LPS	LPS	B-NP	NN	O	30	DEP	O
O	O	O	532	533	)	)	O	)	O	27	NMOD	O
O	O	O	533	534	,	,	O	,	O	5	P	O
O	O	O	535	539	also	also	B-ADVP	RB	O	33	VMOD	O
O	O	O	540	547	exhibit	exhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	548	552	such	such	B-NP	JJ	O	36	AMOD	O
O	O	O	553	554	'	'	I-NP	''	O	36	AMOD	O
O	O	O	554	566	constitutive	constitutive	I-NP	JJ	O	41	NMOD	O
O	O	O	566	567	'	'	I-NP	``	O	41	NMOD	O
T10	B-Entity	B-Entity	568	570	NF	NF	I-NP	NN	B-protein	41	NMOD	B-protein
T10	I-Entity	I-Entity	570	571	-	-	I-NP	HYPH	I-protein	41	NMOD	I-protein
T10	I-Entity	I-Entity	571	576	kappa	kappa	I-NP	NN	I-protein	41	NMOD	I-protein
T10	I-Entity	I-Entity	577	578	B	B	I-NP	NN	I-protein	33	OBJ	I-protein
O	O	O	578	579	,	,	O	,	O	33	P	O
O	O	O	580	582	as	as	B-SBAR	IN	O	33	VMOD	O
O	O	O	583	595	demonstrated	demonstrate	B-VP	VBN	O	43	SBAR	O
O	O	O	596	598	by	by	B-PP	IN	O	44	VMOD	O
O	O	O	599	607	mobility	mobility	B-NP	NN	O	49	NMOD	O
O	O	O	607	608	-	-	I-NP	HYPH	O	49	NMOD	O
O	O	O	608	613	shift	shift	I-NP	NN	O	49	NMOD	O
O	O	O	614	622	analysis	analysis	I-NP	NN	O	45	PMOD	O
O	O	O	623	625	of	of	B-PP	IN	O	49	NMOD	O
O	O	O	626	633	nuclear	nuclear	B-NP	JJ	O	52	NMOD	O
O	O	O	634	642	extracts	extract	I-NP	NNS	O	50	PMOD	O
O	O	O	642	643	.	.	O	.	O	33	P	O

O	O	O	644	648	This	This	B-NP	DT	O	6	NMOD	O
O	O	O	649	656	nuclear	nuclear	I-NP	JJ	B-protein	6	NMOD	B-protein
T11	B-Entity	B-Entity	657	659	NF	NF	I-NP	NN	I-protein	6	NMOD	I-protein
T11	I-Entity	I-Entity	659	660	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T11	I-Entity	I-Entity	660	665	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T11	I-Entity	I-Entity	666	667	B	B	I-NP	NN	I-protein	7	SUB	I-protein
O	O	O	668	671	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	672	677	still	still	B-ADVP	RB	O	7	VMOD	O
O	O	O	678	685	present	present	B-ADJP	JJ	O	7	PRD	O
O	O	O	686	690	when	when	B-ADVP	WRB	O	18	DEP	O
O	O	O	691	702	contaminant	contaminant	B-NP	JJ	O	12	NMOD	O
O	O	O	703	706	LPS	LPS	I-NP	NN	O	13	SUB	O
O	O	O	707	710	was	be	B-VP	VBD	O	10	SBAR	O
O	O	O	711	718	removed	remove	I-VP	VBN	O	13	VC	O
O	O	O	719	721	by	by	B-PP	IN	O	14	VMOD	O
O	O	O	722	737	ultrafiltration	ultrafiltration	B-NP	NN	O	15	PMOD	O
O	O	O	738	741	and	and	O	CC	O	18	DEP	O
O	O	O	742	746	when	when	B-ADVP	WRB	O	7	VMOD	O
O	O	O	747	752	serum	serum	B-NP	NN	O	20	SUB	O
O	O	O	753	756	was	be	B-VP	VBD	O	18	SBAR	O
O	O	O	757	764	omitted	omit	I-VP	VBN	O	20	VC	O
O	O	O	764	765	.	.	O	.	O	7	P	O

O	O	O	766	773	Protein	Protein	B-NP	NN	O	4	NMOD	O
O	O	O	773	774	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	774	777	DNA	DNA	I-NP	NN	O	4	NMOD	O
O	O	O	778	787	complexes	complex	I-NP	NNS	O	11	SUB	O
O	O	O	788	790	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Entity	B-Entity	791	803	constitutive	constitutive	B-NP	JJ	O	5	PMOD	O
T12,T13	I-Entity,B-Entity	I-Entity,B-Entity	804	806	NF	NF	I-NP	NN	B-protein	10	NMOD	B-protein
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	806	807	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	807	812	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	813	814	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	815	818	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	819	826	similar	similar	B-ADJP	JJ	O	11	PRD	O
O	O	O	827	829	in	in	B-PP	IN	O	12	AMOD	O
O	O	O	830	838	mobility	mobility	B-NP	NN	O	13	PMOD	O
O	O	O	839	841	to	to	B-PP	TO	O	12	AMOD	O
O	O	O	842	845	the	the	B-NP	DT	O	17	NMOD	O
T14	B-Entity	B-Entity	846	849	LPS	LPS	I-NP	NN	O	15	PMOD	O
T14	I-Entity	I-Entity	849	850	-	-	B-VP	HYPH	O	17	NMOD	O
T14	I-Entity	I-Entity	850	857	induced	induce	B-NP	VBN	O	23	NMOD	O
T14,T15	I-Entity,B-Entity	I-Entity,B-Entity	858	860	NF	NF	I-NP	NN	B-protein	23	NMOD	B-protein
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	860	861	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	861	866	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	867	868	B	B	I-NP	NN	I-protein	18	OBJ	I-protein
O	O	O	869	872	and	and	O	CC	O	25	NMOD	O
O	O	O	873	877	both	both	B-NP	DT	O	23	NMOD	O
O	O	O	878	881	are	be	B-VP	VBP	O	25	SBAR	O
O	O	O	882	892	recognized	recognize	I-VP	VBN	O	26	VC	O
O	O	O	893	895	by	by	B-PP	IN	O	27	VMOD	O
O	O	O	896	898	an	an	B-NP	DT	O	30	NMOD	O
O	O	O	899	907	antibody	antibody	I-NP	NN	B-protein	28	PMOD	B-protein
O	O	O	908	916	specific	specific	B-ADJP	JJ	O	30	NMOD	O
O	O	O	917	919	to	to	B-PP	TO	O	31	AMOD	O
O	O	O	920	923	the	the	B-NP	DT	O	35	NMOD	O
T1	B-Protein	B-Protein	924	927	p50	p50	I-NP	NN	B-protein	35	NMOD	B-protein
T1	I-Protein	I-Protein	928	935	subunit	subunit	I-NP	NN	I-protein	32	PMOD	I-protein
O	O	O	936	938	of	of	B-PP	IN	O	35	NMOD	O
T16	B-Entity	B-Entity	939	941	NF	NF	B-NP	NN	B-protein	40	NMOD	B-protein
T16	I-Entity	I-Entity	941	942	-	-	B-NP	HYPH	I-protein	40	NMOD	I-protein
T16	I-Entity	I-Entity	942	947	kappa	kappa	I-NP	NN	I-protein	40	NMOD	I-protein
T16	I-Entity	I-Entity	948	949	B	B	I-NP	NN	I-protein	36	PMOD	I-protein
O	O	O	949	950	.	.	O	.	O	11	P	O

O	O	O	951	953	By	By	B-PP	IN	O	13	VMOD	O
O	O	O	954	962	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	962	963	,	,	O	,	O	13	P	O
O	O	O	964	973	treatment	treatment	B-NP	NN	O	13	SUB	O
O	O	O	974	976	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	977	982	cells	cell	B-NP	NNS	O	5	PMOD	O
O	O	O	983	987	with	with	B-PP	IN	O	4	NMOD	O
O	O	O	988	999	pyrrolidine	pyrrolidine	B-NP	NN	O	9	NMOD	O
O	O	O	1000	1015	dithiocarbamate	dithiocarbamate	I-NP	NN	O	7	PMOD	O
O	O	O	1016	1017	(	(	O	(	O	12	DEP	O
O	O	O	1017	1021	PDTC	PDTC	B-NP	NN	O	12	DEP	O
O	O	O	1021	1022	)	)	O	)	O	9	NMOD	O
O	O	O	1023	1027	will	will	B-VP	MD	O	0	ROOT	O
O	O	O	1028	1032	only	only	I-VP	RB	O	13	VMOD	O
O	O	O	1033	1038	block	block	I-VP	VB	O	13	VC	O
T17	B-Entity	B-Entity	1039	1042	LPS	LPS	B-NP	NN	O	22	NMOD	O
T17	I-Entity	I-Entity	1042	1043	-	-	O	HYPH	O	16	P	O
T17	I-Entity	I-Entity	1043	1050	induced	induce	B-NP	VBN	O	16	AMOD	O
T17,T18	I-Entity,B-Entity	I-Entity,B-Entity	1051	1053	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	1053	1054	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	1054	1059	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	1060	1061	B	B	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	1061	1062	,	,	O	,	O	29	P	O
O	O	O	1063	1066	but	but	B-CONJP	CC	O	29	NMOD	O
O	O	O	1067	1070	not	not	I-CONJP	RB	O	24	DEP	O
O	O	O	1071	1074	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1075	1087	constitutive	constitutive	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	O	1088	1095	binding	bind	I-NP	VBG	I-protein	29	NMOD	I-protein
O	O	O	1096	1103	protein	protein	I-NP	NN	I-protein	15	OBJ	I-protein
O	O	O	1103	1104	.	.	O	.	O	13	P	O

O	O	O	1105	1110	Using	Use	B-VP	VBG	O	16	VMOD	O
O	O	O	1111	1114	LPS	LPS	B-NP	NN	O	9	NMOD	O
O	O	O	1114	1115	-	-	O	HYPH	O	9	NMOD	O
O	O	O	1115	1119	free	free	B-NP	JJ	O	9	NMOD	O
O	O	O	1120	1123	and	and	I-NP	CC	O	9	NMOD	O
O	O	O	1124	1129	serum	serum	I-NP	NN	O	9	NMOD	O
O	O	O	1129	1130	-	-	O	HYPH	O	9	NMOD	O
O	O	O	1130	1134	free	free	B-NP	JJ	O	9	NMOD	O
O	O	O	1135	1145	conditions	condition	I-NP	NNS	O	1	OBJ	O
O	O	O	1145	1146	,	,	O	,	O	16	P	O
O	O	O	1147	1159	constitutive	constitutive	B-NP	JJ	O	15	NMOD	O
T19	B-Entity	B-Entity	1160	1162	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T19	I-Entity	I-Entity	1162	1163	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T19	I-Entity	I-Entity	1163	1168	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T19	I-Entity	I-Entity	1169	1170	B	B	I-NP	NN	I-protein	16	SUB	I-protein
O	O	O	1171	1174	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1175	1177	be	be	I-VP	VB	O	16	VC	O
O	O	O	1178	1186	detected	detect	I-VP	VBN	O	17	VC	O
O	O	O	1187	1189	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	1190	1199	different	different	B-NP	JJ	O	19	PMOD	O
O	O	O	1200	1204	cell	cell	I-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	O	1205	1210	lines	line	I-NP	NNS	I-cell_line	20	NMOD	I-cell_line
O	O	O	1211	1213	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1214	1217	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1218	1227	monocytic	monocytic	I-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	O	1228	1235	lineage	lineage	I-NP	NN	I-cell_type	23	PMOD	I-cell_type
O	O	O	1236	1237	(	(	O	(	O	43	DEP	O
O	O	O	1237	1241	HL60	HL60	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	O	1241	1242	,	,	O	,	O	33	P	O
O	O	O	1243	1247	U937	U937	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	O	1247	1248	,	,	O	,	O	33	P	O
O	O	O	1249	1252	THP	THP	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	O	1252	1253	-	-	B-NP	HYPH	I-cell_line	41	NMOD	I-cell_line
O	O	O	1253	1254	1	1	I-NP	CD	I-cell_line	33	NMOD	I-cell_line
O	O	O	1254	1255	,	,	O	,	O	33	P	O
O	O	O	1256	1260	Mono	Mono	B-NP	NN	B-cell_line	37	NMOD	B-cell_line
O	O	O	1261	1264	Mac	Mac	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	1265	1266	1	1	I-NP	CD	I-cell_line	37	NMOD	I-cell_line
O	O	O	1267	1270	and	and	I-NP	CC	O	41	NMOD	O
O	O	O	1271	1275	Mono	Mono	I-NP	NN	B-cell_line	41	NMOD	B-cell_line
O	O	O	1276	1279	Mac	Mac	I-NP	NN	I-cell_line	43	DEP	I-cell_line
O	O	O	1280	1281	6	6	I-NP	CD	I-cell_line	41	NMOD	I-cell_line
O	O	O	1281	1282	)	)	O	)	O	20	NMOD	O
O	O	O	1282	1283	,	,	O	,	O	19	P	O
O	O	O	1284	1287	but	but	B-PP	CC	O	19	PMOD	O
O	O	O	1288	1291	not	not	B-PP	RB	O	47	PMOD	O
O	O	O	1292	1294	in	in	I-PP	IN	O	19	PMOD	O
O	O	O	1295	1299	Molt	Molt	B-NP	NNP	B-cell_line	51	NMOD	B-cell_line
O	O	O	1300	1301	4	4	I-NP	CD	I-cell_line	51	NMOD	I-cell_line
O	O	O	1302	1303	T	T	I-NP	NN	I-cell_line	51	NMOD	I-cell_line
O	O	O	1304	1309	cells	cell	I-NP	NNS	I-cell_line	55	NMOD	I-cell_line
O	O	O	1310	1312	or	or	O	CC	O	55	NMOD	O
O	O	O	1313	1317	K562	K562	B-NP	NN	B-cell_line	55	NMOD	B-cell_line
O	O	O	1318	1322	stem	stem	I-NP	NN	I-cell_line	55	NMOD	I-cell_line
O	O	O	1323	1328	cells	cell	I-NP	NNS	I-cell_line	47	PMOD	I-cell_line
O	O	O	1328	1329	.	.	O	.	O	16	P	O

O	O	O	1330	1334	When	When	B-ADVP	WRB	O	17	VMOD	O
O	O	O	1335	1342	ordered	order	B-VP	VBN	O	1	SBAR	O
O	O	O	1343	1352	according	accord	B-PP	VBG	O	2	VMOD	O
O	O	O	1353	1355	to	to	B-PP	TO	O	3	PMOD	O
O	O	O	1356	1361	stage	stage	B-NP	NN	O	4	PMOD	O
O	O	O	1362	1364	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1365	1375	maturation	maturation	B-NP	NN	O	6	PMOD	O
O	O	O	1375	1376	,	,	O	,	O	17	P	O
O	O	O	1377	1380	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	1381	1387	amount	amount	I-NP	NN	O	17	SUB	O
O	O	O	1388	1390	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1391	1403	constitutive	constitutive	B-NP	JJ	O	11	PMOD	O
T20	B-Entity	B-Entity	1404	1406	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T20	I-Entity	I-Entity	1406	1407	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T20	I-Entity	I-Entity	1407	1412	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T20	I-Entity	I-Entity	1413	1414	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	1415	1418	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1419	1422	not	not	I-VP	RB	O	17	VMOD	O
O	O	O	1423	1432	increased	increase	I-VP	VBN	O	17	VC	O
O	O	O	1433	1435	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	1436	1440	more	more	B-NP	RBR	O	24	NMOD	O
O	O	O	1441	1447	mature	mature	I-NP	JJ	B-cell_line	24	NMOD	B-cell_line
O	O	O	1448	1452	cell	cell	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	1453	1458	lines	line	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	O	1458	1459	.	.	O	.	O	17	P	O

O	O	O	1460	1471	Furthermore	Furthermore	B-ADVP	RB	O	26	VMOD	O
O	O	O	1471	1472	,	,	O	,	O	26	P	O
O	O	O	1473	1477	when	when	B-ADVP	WRB	O	26	VMOD	O
O	O	O	1478	1486	inducing	induce	B-VP	VBG	O	3	SBAR	O
O	O	O	1487	1502	differentiation	differentiation	B-NP	NN	O	4	OBJ	O
O	O	O	1503	1505	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1506	1510	Mono	Mono	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	1511	1514	Mac	Mac	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	1515	1516	6	6	B-NP	CD	I-cell_line	10	NMOD	I-cell_line
O	O	O	1517	1522	cells	cell	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	O	1522	1523	,	,	O	,	O	4	P	O
O	O	O	1524	1528	with	with	B-PP	IN	O	4	VMOD	O
O	O	O	1529	1536	vitamin	vitamin	B-NP	NN	O	14	NMOD	O
O	O	O	1537	1539	D3	D3	I-NP	NN	O	12	PMOD	O
O	O	O	1539	1540	,	,	O	,	O	26	P	O
O	O	O	1541	1543	no	no	B-NP	DT	O	17	NMOD	O
O	O	O	1544	1550	change	change	I-NP	NN	O	26	SUB	O
O	O	O	1551	1553	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	1554	1566	constitutive	constitutive	B-NP	JJ	O	21	AMOD	O
O	O	O	1567	1569	or	or	I-NP	CC	O	21	AMOD	O
O	O	O	1570	1579	inducible	inducible	I-NP	JJ	O	18	PMOD	O
T21	B-Entity	B-Entity	1580	1582	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T21	I-Entity	I-Entity	1582	1583	-	-	B-VP	HYPH	I-protein	25	NMOD	I-protein
T21	I-Entity	I-Entity	1583	1588	kappa	kappa	B-NP	NN	I-protein	25	NMOD	I-protein
T21	I-Entity	I-Entity	1589	1590	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1591	1594	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1595	1597	be	be	I-VP	VB	O	26	VC	O
O	O	O	1598	1606	detected	detect	I-VP	VBN	O	27	VC	O
O	O	O	1606	1607	.	.	O	.	O	26	P	O

O	O	O	1608	1616	Analysis	Analysis	B-NP	NN	O	5	SUB	O
O	O	O	1617	1619	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1620	1627	primary	primary	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	O	1628	1633	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	1634	1642	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	1643	1654	substantial	substantial	B-NP	JJ	O	7	AMOD	O
O	O	O	1655	1667	constitutive	constitutive	I-NP	JJ	O	14	NMOD	O
T22	B-Entity	B-Entity	1668	1670	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T22	I-Entity	I-Entity	1670	1671	-	-	B-VP	HYPH	I-protein	11	P	I-protein
T22	I-Entity	I-Entity	1671	1676	kappa	kappa	B-NP	NN	I-protein	11	NMOD	I-protein
T22	I-Entity	I-Entity	1677	1678	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	1678	1679	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	1679	1686	binding	binding	I-NP	NN	O	14	NMOD	O
O	O	O	1687	1695	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	O	1696	1698	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	1699	1704	blood	blood	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	1705	1714	monocytes	monocyte	I-NP	NNS	I-cell_type	23	NMOD	I-cell_type
O	O	O	1714	1715	,	,	O	,	O	23	P	O
O	O	O	1716	1723	pleural	pleural	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	O	1724	1735	macrophages	macrophage	I-NP	NNS	I-cell_type	23	NMOD	I-cell_type
O	O	O	1736	1739	and	and	O	CC	O	23	NMOD	O
O	O	O	1740	1748	alveolar	alveolar	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	O	1749	1760	macrophages	macrophage	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1760	1761	.	.	O	.	O	5	P	O

O	O	O	1762	1765	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1766	1778	constitutive	constitutive	I-NP	JJ	O	7	SUB	O
T23	B-Entity	B-Entity	1779	1781	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T23	I-Entity	I-Entity	1781	1782	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T23	I-Entity	I-Entity	1782	1787	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T23	I-Entity	I-Entity	1788	1789	B	B	I-NP	NN	I-protein	2	NMOD	I-protein
O	O	O	1790	1797	appears	appear	B-VP	VBZ	O	33	VMOD	O
O	O	O	1798	1800	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	1801	1803	be	be	I-VP	VB	O	7	VMOD	O
O	O	O	1804	1816	functionally	functionally	B-ADJP	RB	O	11	AMOD	O
O	O	O	1817	1823	active	active	I-ADJP	JJ	O	9	PRD	O
O	O	O	1823	1824	,	,	O	,	O	7	P	O
O	O	O	1825	1830	since	since	B-SBAR	IN	O	7	VMOD	O
O	O	O	1831	1832	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	1833	1836	low	low	I-NP	JJ	O	16	NMOD	O
O	O	O	1837	1842	level	level	I-NP	NN	O	25	SUB	O
O	O	O	1843	1845	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1846	1852	tumour	tumour	B-NP	NN	B-RNA	24	NMOD	B-RNA
O	O	O	1853	1861	necrosis	necrosis	I-NP	NN	I-RNA	24	NMOD	I-RNA
O	O	O	1862	1868	factor	factor	I-NP	NN	I-RNA	24	NMOD	I-RNA
O	O	O	1869	1870	(	(	O	(	I-RNA	24	NMOD	I-RNA
O	O	O	1870	1873	TNF	TNF	B-NP	NN	I-RNA	24	NMOD	I-RNA
O	O	O	1873	1874	)	)	O	)	I-RNA	24	NMOD	I-RNA
O	O	O	1875	1885	transcript	transcript	B-NP	NN	I-RNA	17	PMOD	I-RNA
O	O	O	1886	1888	is	be	B-VP	VBZ	O	13	SBAR	O
O	O	O	1889	1899	detectable	detectable	B-ADJP	JJ	O	25	PRD	O
O	O	O	1900	1902	in	in	B-PP	IN	O	26	AMOD	O
O	O	O	1903	1912	monocytes	monocyte	B-NP	NNS	B-cell_type	27	PMOD	B-cell_type
O	O	O	1912	1913	,	,	O	,	O	33	P	O
O	O	O	1914	1917	and	and	O	CC	O	33	VMOD	O
O	O	O	1918	1922	this	this	B-NP	DT	O	32	NMOD	O
O	O	O	1923	1928	level	level	I-NP	NN	O	33	SUB	O
O	O	O	1929	1932	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1933	1935	be	be	I-VP	VB	O	33	VC	O
O	O	O	1936	1945	increased	increase	I-VP	VBN	O	34	VC	O
O	O	O	1946	1948	by	by	B-PP	IN	O	35	VMOD	O
O	O	O	1949	1957	blocking	block	B-VP	VBG	O	36	PMOD	O
O	O	O	1958	1968	transcript	transcript	B-NP	NN	O	39	NMOD	O
O	O	O	1969	1980	degradation	degradation	I-NP	NN	O	37	OBJ	O
O	O	O	1981	1986	using	use	B-VP	VBG	O	37	VMOD	O
O	O	O	1987	2000	cycloheximide	cycloheximide	B-NP	NN	O	40	OBJ	O
O	O	O	2000	2001	.	.	O	.	O	33	P	O

O	O	O	2002	2005	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	2006	2011	level	level	I-NP	NN	O	12	SUB	O
O	O	O	2012	2014	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	2015	2027	constitutive	constitutive	B-NP	JJ	O	8	NMOD	O
T24	B-Entity	B-Entity	2028	2030	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T24	I-Entity	I-Entity	2030	2031	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T24	I-Entity	I-Entity	2031	2036	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T24	I-Entity	I-Entity	2037	2038	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	2039	2041	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	2042	2047	these	these	B-NP	DT	O	11	NMOD	O
O	O	O	2048	2053	cells	cell	I-NP	NNS	O	9	PMOD	O
O	O	O	2054	2056	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	2057	2065	variable	variable	B-ADJP	JJ	O	12	PRD	O
O	O	O	2066	2069	and	and	O	CC	O	12	VMOD	O
O	O	O	2070	2072	is	be	B-VP	VBZ	O	12	VMOD	O
O	O	O	2073	2083	frequently	frequently	I-VP	RB	O	15	VMOD	O
O	O	O	2084	2089	found	find	I-VP	VBN	O	15	VC	O
O	O	O	2090	2092	to	to	I-VP	TO	O	19	VMOD	O
O	O	O	2093	2095	be	be	I-VP	VB	O	17	VMOD	O
O	O	O	2096	2101	lower	low	B-ADJP	JJR	O	19	PRD	O
O	O	O	2102	2104	in	in	B-PP	IN	O	20	AMOD	O
O	O	O	2105	2108	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	2109	2113	more	more	I-NP	RBR	O	25	NMOD	O
O	O	O	2114	2120	mature	mature	I-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	O	2121	2132	macrophages	macrophage	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	O	2132	2133	.	.	O	.	O	12	P	O

O	O	O	2134	2146	Constitutive	Constitutive	B-NP	JJ	O	6	SUB	O
T25	B-Entity	B-Entity	2147	2149	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T25	I-Entity	I-Entity	2149	2150	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T25	I-Entity	I-Entity	2150	2155	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T25	I-Entity	I-Entity	2156	2157	B	B	I-NP	NN	I-protein	1	NMOD	I-protein
O	O	O	2158	2161	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	2162	2165	not	not	I-VP	RB	O	6	VMOD	O
O	O	O	2166	2176	maintained	maintain	I-VP	VBN	O	6	VC	O
O	O	O	2177	2179	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	2180	2189	autocrine	autocrine	B-NP	JJ	O	11	NMOD	O
O	O	O	2190	2196	action	action	I-NP	NN	O	9	PMOD	O
O	O	O	2197	2199	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	2200	2209	cytokines	cytokine	B-NP	NNS	B-protein	34	NMOD	B-protein
O	O	O	2210	2213	TNF	TNF	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	2213	2214	,	,	O	,	O	34	P	O
T2	B-Protein	B-Protein	2215	2226	interleukin	interleukin	B-NP	NN	B-protein	34	NMOD	B-protein
T2	I-Protein	I-Protein	2227	2228	6	6	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	2228	2229	,	,	O	,	O	34	P	O
T3	B-Protein	B-Protein	2230	2241	interleukin	interleukin	B-NP	NN	B-protein	34	NMOD	B-protein
T3	I-Protein	I-Protein	2242	2244	10	10	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	O	2244	2245	,	,	O	,	O	34	P	O
T4	B-Protein	B-Protein	2246	2257	granulocyte	granulocyte	B-NP	NN	B-protein	34	NMOD	B-protein
T4	I-Protein	I-Protein	2257	2258	-	-	O	HYPH	I-protein	34	P	I-protein
T4	I-Protein	I-Protein	2258	2268	macrophage	macrophage	B-NP	NN	I-protein	34	NMOD	I-protein
T4	I-Protein	I-Protein	2269	2275	colony	colony	I-NP	NN	I-protein	34	NMOD	I-protein
T4	I-Protein	I-Protein	2275	2276	-	-	O	HYPH	I-protein	34	P	I-protein
T4	I-Protein	I-Protein	2276	2287	stimulating	stimulate	B-VP	VBG	I-protein	28	NMOD	I-protein
T4	I-Protein	I-Protein	2288	2294	factor	factor	B-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	2295	2297	or	or	O	CC	O	34	NMOD	O
T5	B-Protein	B-Protein	2298	2308	macrophage	macrophage	B-NP	NN	B-protein	31	NMOD	B-protein
T5	I-Protein	I-Protein	2309	2315	colony	colony	I-NP	NN	I-protein	34	NMOD	I-protein
T5	I-Protein	I-Protein	2315	2316	-	-	O	HYPH	I-protein	34	NMOD	I-protein
T5	I-Protein	I-Protein	2316	2327	stimulating	stimulate	B-VP	VBG	I-protein	34	NMOD	I-protein
T5	I-Protein	I-Protein	2328	2334	factor	factor	B-NP	NN	I-protein	12	PMOD	I-protein
O	O	O	2334	2335	,	,	O	,	O	6	P	O
O	O	O	2336	2341	since	since	B-SBAR	IN	O	6	VMOD	O
O	O	O	2342	2354	neutralizing	neutralize	B-VP	VBG	O	38	NMOD	O
O	O	O	2355	2365	antibodies	antibody	B-NP	NNS	O	39	SUB	O
O	O	O	2366	2369	did	do	B-VP	VBD	O	36	SBAR	O
O	O	O	2370	2373	not	not	I-VP	RB	O	39	VMOD	O
O	O	O	2374	2380	reduce	reduce	I-VP	VB	O	39	VC	O
O	O	O	2381	2393	constitutive	constitutive	B-NP	JJ	B-DNA	43	NMOD	B-DNA
O	O	O	2394	2397	DNA	DNA	I-NP	NN	I-DNA	46	NMOD	I-DNA
O	O	O	2397	2398	-	-	O	HYPH	O	46	NMOD	O
O	O	O	2398	2405	binding	binding	B-NP	NN	O	46	NMOD	O
O	O	O	2406	2414	activity	activity	I-NP	NN	O	41	OBJ	O
O	O	O	2414	2415	.	.	O	.	O	6	P	O

O	O	O	2416	2427	Furthermore	Furthermore	B-ADVP	RB	O	9	VMOD	O
O	O	O	2427	2428	,	,	O	,	O	9	P	O
O	O	O	2429	2437	blockade	blockade	B-NP	NN	O	9	SUB	O
O	O	O	2438	2440	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	2441	2454	prostaglandin	prostaglandin	B-NP	NN	O	8	NMOD	O
O	O	O	2455	2457	or	or	I-NP	CC	O	8	NMOD	O
O	O	O	2458	2469	leukotriene	leukotriene	I-NP	NN	O	8	NMOD	O
O	O	O	2470	2482	biosynthesis	biosynthesis	I-NP	NN	O	4	PMOD	O
O	O	O	2483	2486	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	2487	2490	not	not	I-VP	RB	O	9	VMOD	O
O	O	O	2491	2497	affect	affect	I-VP	VB	O	9	VC	O
O	O	O	2498	2510	constitutive	constitutive	B-NP	JJ	O	11	OBJ	O
T26	B-Entity	B-Entity	2511	2513	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T26	I-Entity	I-Entity	2513	2514	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T26	I-Entity	I-Entity	2514	2519	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T26	I-Entity	I-Entity	2520	2521	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	2521	2522	.	.	O	.	O	9	P	O

O	O	O	2523	2524	(	(	O	(	O	7	DEP	O
O	O	O	2524	2532	ABSTRACT	ABSTRACT	B-NP	NN	O	7	DEP	O
O	O	O	2533	2542	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD	O
O	O	O	2543	2545	AT	AT	B-PP	IN	O	3	VMOD	O
O	O	O	2546	2549	400	400	B-NP	CD	O	6	NMOD	O
O	O	O	2550	2555	WORDS	WORDS	I-NP	NNS	O	4	PMOD	O
O	O	O	2555	2556	)	)	O	)	O	0	ROOT	O
